ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
167 hedge funds and large institutions have $1.41B invested in Array Biopharma Inc in 2016 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 35
1% less funds holding
Funds holding: 169 → 167 (-2)
Holders
167
Holding in Top 10
6
Calls
$12.7M
Puts
$7.38M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$23.9M | |
| 3 | +$22M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.2M |
| 5 |
O
OrbiMed
New York
|
+$16.8M |
Top Sellers
| 1 | -$32M | |
| 2 | -$29M | |
| 3 | -$19.8M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$13M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.53M |